Adverse Events in Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Adverse Events in Clinical Trials in Colombia

Adverse Events in Clinical Trials in Colombia – Clinical Research in LATAM

Clinical trials form the bedrock of medical research, providing invaluable data on the safety and efficacy of new treatments and medications. These trials are conducted to evaluate the potential benefits and risks of experimental drugs before they can be approved for wider use.

In the context of clinical research, monitoring and reporting adverse events (AEs) are of paramount importance. Adverse events refer to any undesirable or harmful effects experienced by study participants during the course of a trial. This blog examines the significance of adverse event reporting in Colombia and the measures taken to uphold ethical standards and ensure patient safety in clinical trials.

The Significance of Clinical Trials in Colombia

Clinical trials play a vital role in advancing medical knowledge and enhancing healthcare outcomes for patients in Colombia. By participating in clinical trials, patients gain access to innovative therapies that are not yet widely available, and they contribute to the development of groundbreaking treatments that address unmet medical needs.

Furthermore, these trials help shape evidence-based medical practices, leading to improved healthcare delivery and better health outcomes for the population.

Upholding Ethical Standards in Clinical Trials

To safeguard the rights and safety of participants, clinical trials in Colombia are subject to rigorous regulations and oversight by the Colombian National Food and Drug Surveillance Institute (INVIMA) and the Ministry of Health and Social Protection.

These regulatory bodies enforce compliance with international guidelines such as the Declaration of Helsinki and the Good Clinical Practice (GCP) guidelines established by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

The Role of Adverse Event Reporting

Adverse event reporting is a crucial aspect of clinical trials that aims to identify, document, and manage any unexpected or undesirable effects experienced by study participants. This process is fundamental in comprehensively assessing the safety profile of an investigational drug. When adverse events occur, researchers have a responsibility to take prompt and appropriate actions to protect the well-being of participants and ensure the integrity of the trial.

Challenges in Adverse Event Reporting

Despite the stringent regulations in place, the reporting of adverse events in clinical trials can present challenges. Some common challenges include underreporting by healthcare professionals, lack of awareness about reporting procedures, and communication gaps among stakeholders involved in the trial. These challenges can hinder the accurate assessment of a drug’s safety profile, potentially jeopardizing patient safety and the overall validity of the trial results.

Adverse Events in Clinical Trials in Colombia

Adverse Events in Clinical Trials in Colombia

Adverse Events in Clinical Trials in Colombia

Addressing Challenges and Enhancing Patient Safety

To address the challenges associated with adverse event reporting, various strategies are implemented in Colombia. These include:

  1. Training and Education: Healthcare professionals engaged in clinical trials receive training on adverse event reporting, emphasizing the importance of timely and accurate documentation. Additionally, participants are educated about potential risks and how to report any adverse events they may experience during the trial.
  2. Pharmacovigilance Systems: Robust pharmacovigilance systems are established to continuously monitor the safety of approved drugs, enabling the timely identification and reporting of adverse events post-approval.
  3. Independent Data Monitoring Committees (DMCs): DMCs are constituted to review trial data, including adverse events, independently and objectively. These committees play a vital role in ensuring participant safety and making informed decisions about the continuation or modification of the trial.
  4. Transparent Communication: Effective communication among all stakeholders, including researchers, sponsors, and regulatory authorities, is essential to ensure that adverse events are promptly communicated and appropriately addressed.
  5. Collaborating with International Bodies: Colombia collaborates with international organizations and regulatory agencies to align its standards with global best practices, promoting patient safety and elevating the credibility of its clinical research.


Adverse event reporting in clinical trials is a critical process that prioritizes the safety and well-being of study participants while maintaining the scientific integrity of the research. In Colombia, regulatory authorities and researchers work together to ensure that clinical trials are conducted ethically, adhering to stringent guidelines and standards.

By fostering transparent communication, promoting education, and addressing challenges, Colombia continues to contribute significantly to medical advancements and the improvement of healthcare outcomes through responsible and safe clinical research.

As Colombia strives to provide the best possible healthcare for its citizens and contribute to global medical progress, the commitment to ethical clinical research remains central in ensuring patient safety and the advancement of medical knowledge.

Adverse Events in Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Adverse Events in Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Adverse Events in Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Adverse Events in Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Adverse Events in Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Adverse Events in Clinical Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Adverse Events in Clinical Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Adverse Events in Clinical Trials in Colombia

The Cohortias Team

Adverse Events in Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Adverse Events in Clinical Trials in Colombia

Network & Partnerships